Reinhart Manuel, Metze Dieter, Braun Stephan A
Klinik für Hautkrankheiten, Universitätsklinikum Münster, Von-Esmarch-Str. 58, 48149, Münster, Deutschland.
Klinik für Dermatologie, Medizinische Fakultät, Heinrich-Heine-Universität, Düsseldorf, Deutschland.
Hautarzt. 2022 Jun;73(6):434-441. doi: 10.1007/s00105-022-04991-w. Epub 2022 Apr 27.
Coronavirus disease 2019 (COVID-19) is a systemic disease induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that frequently presents with skin manifestations. The five most common skin lesions are pseudo-chilblain and maculopapular, urticarial, vesicular, and livedo/necrotizing skin lesions. These skin lesions are of diagnostic and prognostic relevance. For example, in children, typical skin lesions may indicate a life-threatening inflammatory syndrome, which rarely occurs after corona infection. Skin lesions have also been described after COVID-19 vaccination. These usually show an uncomplicated, self-limiting course and therefore do not represent a contraindication for completing the vaccination status in the vast majority of cases.
2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的一种全身性疾病,常伴有皮肤表现。最常见的五种皮肤病变为冻疮样疹和斑丘疹、荨麻疹、水疱以及网状青斑/坏死性皮肤病变。这些皮肤病变具有诊断和预后意义。例如,在儿童中,典型的皮肤病变可能预示着一种危及生命的炎症综合征,这种情况在新冠感染后很少发生。COVID-19疫苗接种后也有皮肤病变的报道。这些病变通常呈病情不复杂、自限性的病程,因此在绝大多数情况下并不构成完成疫苗接种程序的禁忌证。